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The analysis of the first 10,000 cases of influenza A(H1N1)v 
in Germany confirms findings from other sources that the virus 
is currently mainly causing mild diseases, affecting mostly 
adolescents and young adults. Overall hospitalisation rate for 
influenza A(H1N1)v was low (7%). Only 3% of the cases had 
underlying conditions and pneumonia was rare (0.4%). Both 
reporting and testing requirements have been adapted recently, 
taking into consideration the additional information available on 
influenza A(H1N1)v infections.
Introduction
After the first cases of influenza A(H1N1)v in the United States 
and Mexico became public, the Robert Koch Institute (RKI) 
established a case-based reporting of cases of influenza A(H1N1)
v [1]. In the first weeks of the pandemic, data were reported to the 
national level by fax, phone and email in parallel with the routine 
electronic reporting system SurvNet [2]. Thereafter, this changed to 
exclusive electronic data reporting, including additional information 
relevant for the assessment of the epidemiological situation. 
After the detailed examination of the first 100 cases in the early 
phase of the pandemic [1], we analyse here data of the first 9,950 
cases in Germany, with a focus on information regarding the risk 
groups, hospitalisation frequency and other factors contributing to 
the impact this pandemic has on the healthcare system, in order 
to guide further public health measures.
Methods
As of 30 April 2009 the following information was collected 
through SurvNet with standardised free-text: classification of 
cases (possible, probable, confirmed, discarded case), in-country 
transmission, number of contacts (close as well as wider contacts), 
antiviral drug used. From 22 June 2009 onwards, the variables were 
changed in order to collect more detailed data on treatment (start 
of therapy, antiviral drug), risk groups, presence of pneumonia, 
hospitalisation and source of infection. 
In order to take the age structure of the population into 
consideration, we calculated the incidence per 100,000 population 
per age group. From our data, we also calculated the time interval 
between date of symptom onset and diagnosis and start of therapy, 
respectively.
Categorical variables were presented as percentages with 
interquartile ranges when appropriate. Odds ratios were calculated 
including 95% confidence intervals where appropriate. 
Results
As of 25 August 2009, 14,940 cases of influenza A(H1N1)v 
have been reported in Germany. For the detailed report below we 
analysed the first 9,950 cases that were reported to the RKI until 
10 August 2009. 
The date of symptoms onset of the first German case was 20 
April 2009. The person had travelled to Mexico and had already 
become symptomatic while staying in Mexico. Until the end of May, 
only sporadic cases were notified, usually associated with travel to 
North America. Most secondary infections with influenza A(H1N1)
v which occurred in this period could be traced back to returning 
travellers. In June, the number of new cases rose to approximately 
10 to 50 cases per day. Since mid-July we saw a considerable 
increase in cases in Germany (Figure 1) with a peak of up to 500 
cases per day and 3,000 cases per week at the end of July. Since 
then, the number of new cases per day has decreased.
From the 9,950 cases, 54% were male. The median age was 
19 years (range: 0-89 years). The majority of cases (77%) were 
from 10 to 29 years old. Two per cent of the cases were younger 
than five years, 3% were between five and nine years old, 17% 
were between 30 to 59 years old and less than 1% of the reported 
cases were 60 years old and older. 
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Notified cases of influenza A(H1N1)v by week of symptom 
onset, Germany, April-August 2009, (n=9,275 cases with 
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Looking at the incidence (Figure 2), the 15 to 19 year-olds were 
most affected, with 90 cases per 100,000 population, followed by 
the 20 to 24 year-olds (43/100,000). In children up to two years 
old, there were 5.5 cases per 100,000 population. Persons 60 
years old and older had less than one case per 100,000 population. 
The proportion of incidence by age group over the weeks 28 to 32 
showed a stable age distribution over this time period (Figure 3). 
For 2,141 cases (22%), Germany was indicated as the most 
likely country of infection. In the first weeks of the pandemic 
(May and June), most travel-associated cases had been returning 
travellers from North America. Since the first week in July, the 
proportion of infections associated with travel to European countries 
has risen sharply. In July, 80% of travel-associated infections were 
seen in travellers returning from Spain, followed by the United 
Kingdom (6%), Bulgaria (3%) and North America (2%). From week 
F i g u r e  3
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29 to 32, the number of cases most likely infected in Germany rose 
steadily from 16% to 24%. For the cases without travel history, the 
proportion of infections without a known source increased between 
weeks 29 and 32 from 38% to 43% (n=1,039).  
Symptoms were reported for all 9,950 cases. Cough was the 
most common symptom, present in 82% of the cases, followed 
by fever (78%). 
Data were also collected on underlying health conditions and 
risk factors. The results are presented in the table.  
The average time interval between date of symptom onset and 
diagnosis (n=7,955 cases for whom this information was available) 
was 3.6 days with an increasing trend from week 26 (2.4 days) to 
week 31 (3.8 days). The average time between date of symptom 
onset and start of therapy (n=1,810 cases for whom this information 
was available) was 2.2 days with a decreasing trend from week 28 
(4.0 days) to week 32 (2.0 days). Cases with underlying conditions 
were more likely to receive treatment (72/134: 54%) than cases 
without underlying conditions (1,679/3,805: 45%; OR=1.44 
[1.01; 2.07]). Information on presence of pneumonia at the time of 
notification was available for 6,460 cases. Pneumonia was reported 
for 26 cases (0.4%), out of which four belonged to a risk group 
(two had respiratory, two had unspecified risk factors) and eight 
were hospitalised.
From 3,630 cases for whom hospitalisation status was available, 
263 (7%) persons were admitted to a hospital because of influenza, 
122 cases (3%) were in hospital for other reasons, and for 42 cases 
(1%) the reason of hospitalisation was not known. The influenza 
hospitalisation rate changed from 11% in week 29 to 5% in week 
31. We also looked for cases with information on their risk factors 
and their hospitalisation status (n=3,270). The proportion of people 
with risk factors who were hospitalised for influenza was 19% 
(20/108), while the proportion of people without risk factors that 
were hospitalised for influenza was 7% (220/3,162; OR = 3.04 
[1.78; 5.16]). The median age was 19 years for both groups.
During the first phase of the pandemic, all contacts of cases in 
Germany were traced back by the local public health authorities 
and the number of contacts was reported to the national level. The 
trace back was done for 2,635 cases. On average, three contact 
persons per case were identified (upper and lower quartile: 2 to 6 
contacts, range 0 to 330 contacts). 
Discussion
The analysis of the first approximately 10,000 cases of influenza 
A(H1N1)v in Germany showed that after some sporadic cases and a 
slow increase in June 2009, a significant increase of newly reported 
cases was seen starting with July. This trend was also reported 
from other countries in Europe [3]. There seems to be a downward 
trend now in Germany, even taking into account a reporting delay 
of approximately one week. Whether this decrease is a true decline 
in incidence is not yet clear. A change in health-seeking behaviour 
might also play a role. The first anxiety about the new infection 
might have made more people with respiratory symptoms seek 
medical advice and therefore might have brought the cases to the 
attention of the of the public health authorities. However, other 
European countries, like the UK, also report signs that the potential 
first wave of the pandemic might be coming to an end [4].
The cumulative number of cases by age group clearly shows that 
there is a peak in the age group 15 to 19 years . Many of these 
cases were high-school graduates who travelled to Spain in large 
groups at the end of the school year. The incidence in the under 
two year old children is relatively low (5/100,000). Data from the 
United States showed a much higher incidence (22.9/100,000) in 
children up to five years old [5]. The very low incidence in people 
over 60 years of age is consistent with other investigations [4-7]. 
It is still unclear if this is due to a partial immunity from former 
infections with H1N1 influenza viruses or if this is because the 
virus has not yet been sufficiently introduced in this subpopulation. 
Looking at the proportion of affected age groups over weeks, no 
shift to the older (>60 years) or younger (<5 years) age groups can 
be seen yet.
The high proportion of cases imported from Spain does not 
necessarily indicate a relevant epidemic activity there, but probably 
rather reflects the travel patterns of German holiday makers during 
summer. The German Federal Office for Statistics reported that from 
June to August 2008 approximately 1.1 million people travelled 
every month from Germany to Spain by air [8]. Additionally, there 
are many organised bus tours to Spain that are especially favoured 
by high-school students. Closer physical contact, sharing of drinks 
and special party settings were discussed as possible risk factors, 
but they need to be validated by further research. Besides the high 
number of cases in travellers, we could see an increasing proportion 
of cases that had no travel history and no known source of infection 
in the last weeks.
Most cases of influenza A(H1N1)v currently seem to have 
uncomplicated influenza-like illnesses. Our data show that the 
most common symptoms were cough and fever, similarly to reports 
from other countries [6-9]. This was one of the reasons why we 
specified the list of symptoms for the physicians to notify a patient 
to the local health authorities. 
A particular interest for the public health authorities is 
the protection of the vulnerable groups. These are people 
with underlying conditions, such as chronic diseases, but also 
pregnancy, who have a higher risk of developing complications 
during an influenza infection. From all notified cases in Germany 
for whom the information was available, only 3% had underlying 
T a b l e
Frequency of underlying health conditions for cases of 
influenza A(H1N1)v, Germany, April-August 2009, (n=5,885 
cases for whom this information was available)
Underlying conditions* Number of cases (%) Proportion of all underlying conditions 
No 5,690 (96.7%) -
Yes 195 (3.3%) -
Respiratory disease 87 (1.5%) 45%
Cardio-vascular disease 29 (0.5%) 15%
Diabetes 17 (0.3%) 9%
Obesity 11 (0.2%) 6%
Pregnancy 9 (0.2%) 5%
Immunsuppression 5 (0.1%) 3%
Others 34 (0.6%) 17%
Not specified 9 (0.2%) 5%
*Multiple answers were possible.
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conditions. Nearly half of them had chronic respiratory tract 
diseases. Pregnancy was not often reported among the confirmed 
cases. Pneumonia at the time of notification was also very rarely 
reported.
With increasing numbers of cases and laboratory diagnoses, 
the time interval between date of onset of symptoms and date 
of diagnosis has increased considerably. In the beginning, both 
transport of specimens and laboratory testing were done very fast. 
Now diagnostics have become more routine work and the high 
number of samples has caused a backlog of samples to be tested. 
The time interval between onset of symptoms and start of therapy 
decreased from four to two days. That means physicians start 
therapy as recommended before the laboratory confirmation of 
the influenza infection. Treatment is started on average within 48 
hours from symptom onset, when the antiviral drugs are supposed 
to be most effective. 
The hospitalisation rate changed considerably over the weeks. 
During the first weeks, the majority of cases were hospitalised 
due to infection control measures. Even though that might still 
be the case for some patients, hospitalisation is now considered 
as a proxy for the severity of the disease in patients. In the last 
couple of weeks, the hospitalisation rate due to influenza in the 
notified cases halved to 5% in week 32. This is a relatively low 
proportion and does not constitute a high burden for the hospitals 
at this stage of the pandemic. When we looked closer at those 
cases with reported underlying conditions we could see that they 
had a hospitalisation rate more than two times higher than in 
cases without underlying conditions. Here precaution could have 
contributed to the referral to a hospital, but it still shows that these 
known groups with underlying conditions will present an important 
group when dealing with the pandemic. 
Conclusion
As of August 2009, the majority of influenza A(H1N1)v cases 
reported in Germany are mainly imported from other European 
countries. However, the proportion of cases with in-country 
transmission is increasing.
Several factors might influence the characteristics of notified 
cases in the near future. Firstly, as of 18 August 2009, physicians 
have to notify possible cases only if the patient presents with cough 
and fever, therefore it is assumed that the number of cases reported 
to the national level will decrease. Since 17 August 2009, the 
costs of the laboratory confirmation have been paid by the statutory 
health insurances only for cases with severe disease or cases with 
the risk to develop severe disease. Therefore, the percentage of 
laboratory-confirmed cases among the notified cases will decrease. 
However, as long as the sentinel surveillance in Germany does not 
give a signal, the assessment of the epidemiological situation must 
rely on routine surveillance. 
The public health strategy has changed in Germany from 
containment (follow-up of all contact persons) to the protection of 
vulnerable groups. Now, only contact persons who have occupational 
contacts to persons with a high risk to develop severe disease are 
followed up (e.g.: healthcare workers).  
Until now, no fatalities due to influenza A(H1N1)v have been 
reported in Germany, which may be partly due to these strategies.
Germany wants to continue the current reporting system until 
the number of respiratory infections increases significantly, as can 
be expected in autumn again. Then it is planned to stop the case-
based reporting by physicians and get the necessary information 
from the laboratory-based reporting of confirmed cases as it is 
done for seasonal influenza viruses and the sentinel surveillance.
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